Sanofi/91亚色 Industry Fellowship Program

Home - Academics - Nesbitt School of Pharmacy - Sanofi / 91亚色 Pharmaceutical Industry Fellowship Program

The Sanofi and 91亚色 two-year Pharmaceutical Industry Fellowship Program offers Doctor of Pharmacy graduates a comprehensive experience. This program provides opportunities in various functional areas within multiple Global Business Units.

Fellowships Offered

Pharmacovigilance Fellowships

The Fellow will have the opportunity to rotate across the various Sanofi Global Business Units within Pharmacovigilance.

Pharmacovigilance Fellowship

Recruiting One Fellow In Specialty Care

US Medical Affairs Fellowship

The Fellow will have the opportunity to rotate across Sanofi Vaccines in multiple Medical Affairs areas, such as Field-Based Medical Team (Medical Science Liaison), Medical Strategy, Health Economics and Outcomes, and Omnichannel.

US Medical Affairs Fellowship

Recruiting Two Fellows in Vaccines

Periodic Safety Reports and Literature Surveillance Fellowship

The Fellow will have the opportunity to develop expertise in various pharmacovigilance operational activities including Periodic Safety Report (PSR) planning, PSR coordination and Literature Surveillance.

PERIODIC SAFETY REPORTS AND LITERATURE Surveillance FELLOWSHIP

Not Recruiting

Contact

Dr. Thomas Franko

Associate Professor and Chair

thomas.franko@wilkes.edu

Sanofi/91亚色 Industry Fellowship Brochure (.pdf)

Company Overview

Around the world, more than 100,000 people at Sanofi are dedicated to chasing the miracles of science to improve people鈥檚 lives. Our promise to our employees is to pursue progress and discover extraordinary together: better science, better medications, better outcomes. All that progress needs people. People from diverse backgrounds, in various places around the world, performing distinct roles all united by one thing: a desire to chase the miracles of science to improve people鈥檚 lives.

Our employees are people who:

  • Explore more, sharing our purpose and our skills.
  • Chase change and embrace innovative ideas.
  • Do right for our business, patients, society, and the planet. We are committed to making the right decision and taking action even when it is the harder thing to do.
  • Make miracles, taking thoughtful risks to find better solutions for the people we serve.

About Sanofi

Sanofi is structured with four Global Business Units to support the company鈥檚 Play to Win strategy:

  • Specialty Care
  • Vaccines
  • General Medicines
  • Consumer Healthcare (a standalone business unit)

As of July 2024, the R&D pipeline contained:

  • 77 projects
  • 30 projects are in phase 3 or have been submitted to regulatory authorities for approval

We are committed to high standards of manufacturing excellence and our people produce healthcare solutions to prevent and manage a broad spectrum of medical conditions.

  • 鈧�1 billion invested annually in modernizing our supply network
  • 170 countries served by our distribution operations
  • More than 4.8 billion units of pharmaceuticals, consumer healthcare products, and vaccines including those generated from in-house and outsourced production, sold annually

Our Journey in Vaccines

Sanofi has been a leader in vaccines for more than 100 years. The combination of our innovative vaccines and global reach means that many diseases do not hold the power they once did. Our determination to improve public health motivates us to develop new vaccines to address still unmet medical needs.

Fueled by new data and digital technologies, our science and manufacturing have the potential to transform the practice of medicine for millions of people around the world. And when we discover the extraordinary, we鈥檙e already planning where to go next. Because everyone deserves a chance to plan for their future, to dream big.

Our vaccines are available in ~150 countries

500 million people vaccinated annually with our vaccines, worldwide

2.5 million vaccine doses supplied, every day